Current HIV‐2 diagnostic strategy overestimates HIV‐2 prevalence in China
- 24 March 2009
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 81 (5) , 790-797
Abstract
A significant number of HIV‐2 infections have been reported in China using Western blot as per current guidelines for HIV‐2 diagnosis in China. However, most specimens were also positive on HIV‐1 Western blot suggesting cross‐reactivity and possible overestimation. We carried out the current study to evaluate a strategy to diagnose the HIV‐2 infections in China. A total of 119 specimens received from 16 provinces were likely to be HIV‐2 when tested according to current guidelines in China using the Genelabs Western blot (HIV Blot 2.2 WB). Further testing by HIV‐2 WB (Bio‐Rad New LAV Blot II or Genelabs HIV Blot 1.2 WB) scored 56 (47.1%) of 119 samples with banding pattern suggestive of HIV‐2 infection, and 63 (52.9%) were HIV‐2 indeterminate. A peptide‐based HIV‐1 and HIV‐2 enzyme immunoassay for differential diagnosis of HIV‐1 and HIV‐2 infections was validated and used. This in‐house EIA demonstrated that only 1 (0.8%) of 119 specimens had HIV‐2 specific antibodies, while 2 (1.7%) were dually reactive. These results were highly concordant (>99%) with those by Inno‐LIA HIV‐I/II (Innogenetics, Belgium), which also use specific peptides for type‐specific diagnosis. Our data demonstrates that HIV‐2 infection is rare in China, and HIV‐2 Western blot may overestimate the prevalence of HIV‐2 in the population with HIV‐1. The HIV‐2 diagnostic strategy in China needs to be revised to include more specific peptide‐based immunoassays. J. Med. Virol. 81:790–797, 2009.Keywords
This publication has 23 references indexed in Scilit:
- Infection with the Human Immunodeficiency Virus Type 2Annals of Internal Medicine, 1993
- Prevalence of HIV-1 and HIV-2 mixed infections in Côte d'IvoireThe Lancet, 1992
- Oligomeric nature of transmembrane glycoproteins of HIV-2AIDS, 1991
- Rapid and specific diagnosis of HIV-1 and HIV-2 infectionsAIDS, 1990
- Discrimination of HIV-2 Infection from HIV-1 Infection by Western Blot and Radioimmunoprecipitation AnalysisAIDS Research and Human Retroviruses, 1990
- The Chemistry of Site-Directed Serology for HIV InfectionsAIDS Research and Human Retroviruses, 1989
- [44] Custom-designed synthetic peptide immunoassays for distinguishing HIV type 1 and type 2 infections1989
- Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoproteinAIDS, 1989
- Discrimination between antibodies to HIV and to related retroviruses using site-directed serologyNature, 1987
- Site‐directed ELISA with synthetic peptides representing the HIV transmembrane glycoproteinJournal of Medical Virology, 1987